Scientists from University of Helsinki Institute of Biotechnology have identified a novel therapeutic target for Parkinson's disease.
Lead researcher Professor Raimo K. Tuominen and colleagues have identified a growth factor that can be used to halt the progress of damage brought on by a nerve poison, and possibly restore the function of damaged cells.
Parkinson’s Disease - Causes, Symptoms, Diagnosis, Treatment
Parkinson’s disease is a neurodegenerative disease caused by progressive dopamine brain cells loss. Symptoms of Parkinson’s disease are correctable to an extent.
Parkinson’s disease is a neurodegenerative disease caused by progressive dopamine brain cells loss. Symptoms of Parkinson’s disease are correctable to an extent.
MANF is released from glial cells in the midbrain and is a member of the same growth factor family as CDNF.
The team found that in the experimental PD model, MANF and CDNF injections into the brain prevented dopamine nerve destruction caused by nerve poison and to some extent even restored the function of damaged cells in rats.
About Parkinson's Disease
Parkinson's Disease is a chronic, progressive, brain disorder common among the elderly. It affects coordination between the brain and the muscles
Parkinson's Disease is a chronic, progressive, brain disorder common among the elderly. It affects coordination between the brain and the muscles
This may be a highly significant finding in respect to the development of growth factor therapy for PD.
Advertisement
Parkinson's Disease
Slide animation on Parkinson disease. It is a progressive movement disorder due to degeneration of nerve cells of the substantia nigra of the brain. The symptoms get worse with time but drugs or surgery can control them. PD cannot be cured.
Slide animation on Parkinson disease. It is a progressive movement disorder due to degeneration of nerve cells of the substantia nigra of the brain. The symptoms get worse with time but drugs or surgery can control them. PD cannot be cured.
SRM
Stem Cell Transplant for Parkinson's Performed at Jaslok Hospital
A rare stem cell transplant for Parkinson’s diseases was performed at Jaslok Hospital on 54-year-old Bhanwarlal Jain who was suffering an advanced stage of the disease.
A rare stem cell transplant for Parkinson’s diseases was performed at Jaslok Hospital on 54-year-old Bhanwarlal Jain who was suffering an advanced stage of the disease.
